Research ArticleClinical Studies
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
Anticancer Research October 2022, 42 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15995
YUKI FUJIMOTO
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
TADASHI NAMISAKI
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
SOICHI TAKEDA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
KOJI MURATA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
MASAHIDE ENOMOTO
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
HIROAKI TAKAYA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
YUKI TSUJI
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
YUKIHISA FUJINAGA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
YASUHIKO SAWADA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
NORIHISA NISHIMURA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
KOH KITAGAWA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
KOSUKE KAJI
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
TAKASHI INOUE
2Department of Evidence-Based Medicine, Nara Medical University Hospital, Nara, Japan
HIDETO KAWARATANI
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
KEI MORIYA
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
TAKEMI AKAHANE
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
AKIRA MITORO
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
HITOSHI YOSHIJI
1Department of Gastroenterology, Nara Medical University, Nara, Japan;
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO, HITOSHI YOSHIJI
Anticancer Research Oct 2022, 42 (10) 4895-4905; DOI: 10.21873/anticanres.15995
Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO, HITOSHI YOSHIJI
Anticancer Research Oct 2022, 42 (10) 4895-4905; DOI: 10.21873/anticanres.15995
Jump to section
Related Articles
- No related articles found.